Provided by Tiger Trade Technology Pte. Ltd.

Coherus BioSciences

1.21
+0.03002.54%
Post-market: 1.210.00000.00%16:10 EDT
Volume:1.58M
Turnover:1.89M
Market Cap:186.60M
PE:-1.21
High:1.23
Open:1.18
Low:1.16
Close:1.18
52wk High:2.62
52wk Low:1.09
Shares:154.22M
Float Shares:136.00M
Volume Ratio:1.14
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0011
EPS(LYR):1.43
ROE:-178.39%
ROA:-30.52%
PB:3.07
PE(LYR):0.84

Loading ...

Coherus Oncology - Initiates Process to Sell Legacy Biosim Assets

THOMSON REUTERS
·
Sep 23

Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets

GlobeNewswire
·
Sep 23

H.C. Wainwright Keeps Their Buy Rating on Coherus Biosciences (CHRS)

TIPRANKS
·
Sep 22

Coherus to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Aug 31

Coherus Oncology Enters ATM Equity Sales Agreement for up to $50 Million Common Stock Offering

Reuters
·
Aug 29

Coherus Oncology - Offering up to $50 Mln of Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 29

Coherus Oncology - Terminates Continuous Offering Under January 2026 Prospectus and Sales Agreement - SEC Filing

THOMSON REUTERS
·
Aug 29

Coherus Declares Special Dividend of Biosimilar Contingent Value Rights, Payable Oct. 7 to Holders of Record Sept. 30

MT Newswires Live
·
Aug 18

Coherus Oncology issuing special dividend of biosimilar contingent value rights

TIPRANKS
·
Aug 18

Coherus Oncology - to Begin Sale Process for Legacy Biosimilar Assets

THOMSON REUTERS
·
Aug 18

Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights

THOMSON REUTERS
·
Aug 18

Coherus Oncology Declares CVR Dividend Tied to Sale of Remaining Biosimilar Assets

Reuters
·
Aug 18

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 08

Coherus Oncology Price Target Cut to $10.00/Share from $12.00 by Guggenheim

Dow Jones
·
Aug 08

TriSalus Life Sciences Q2 Revenue Beats Estimates

Reuters
·
Aug 07

Verastem Q2 Revenue Jumps on New Product Sales and Milestone

Reuters
·
Aug 07

CG Oncology Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 06

Delcath Systems Q2 Revenue Rises, Beats Estimates

Reuters
·
Aug 06

Nuvation Bio Q2 Revenue Beats Estimates on Ibtrozi Growth

Reuters
·
Aug 06

UK's Immunocore Q2 EPS Misses Estimates

Reuters
·
Aug 06